Sequence information
Variant position: 127 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 147 The length of the canonical sequence.
Location on the sequence:
LGNVLVCVLAHHFGKEFTPP
V QAAYQKVVAGVANALAHKYH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LGNVLVCVLAHHFGKEFTPPV QAAYQKVVAGVANALAHKYH
Gorilla LGNVLVCVLAHHFGKEFTPPV QAAYQKVVAGVANALAHKYH
Rhesus macaque LGNVLVCVLAHHFGKEFTPQV QAAYQKVVAGVANALAHKYH
Chimpanzee LGNVLVCVLAHHFGKEFTPPV QAAYQKVVAGVANALAHKYH
Pig LGNVIVVVLARRLGHDFNPNV QAAFQKVVAGVANALAHKYH
Bovine LGNVLVVVLARNFGKEFTPVL QADFQKVVAGVANALAHRYH
Rabbit LGNVLVIVLSHHFGKEFTPQV QAAYQKVVAGVANALAHKYH
Sheep LGNVLVVVLARHHGNEFTPVL QADFQKVVAGVANALAHKYH
Cat LGNVLVCVLAHHFGHDFNPQV QAAFQKVVAGVANALAHKYH
Horse LGNVLVVVLARHFGKDFTPEL QASYQKVVAGVANALAHKYH
Chicken LGDILIIVLAAHFSKDFTPEC QAAWQKLVRVVAHALARKYH
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 147
Hemoglobin subunit beta
Binding site
144 – 144
Modified residue
145 – 145
N6-acetyllysine; alternate
Glycosylation
121 – 121
N-linked (Glc) (glycation) lysine
Glycosylation
145 – 145
N-linked (Glc) (glycation) lysine; alternate
Helix
125 – 143
Literature citations
Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val-->Gly: a new unstable beta variant producing a beta-thalassemia intermedia phenotype in association with beta zero-thalassemia.
Bardakdjian-Michau J.; Fucharoen S.; Delanoe-Garin J.; Kister J.; Lacombe C.; Winichagoon P.; Blouquit Y.; Riou J.; Wasi P.; Galacteros F.;
Am. J. Hematol. 35:96-99(1990)
Cited for: VARIANT B-THAL GLY-127;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.